The Pharmaceutical Industry: Health, Illness, and Innovation Dynamics

This chapter examines the pharmaceutical industry's practices during the COVID-19 pandemic, highlighting its focus on profit over public health. The discussion reveals how the sector's incentive structure impacts the perception of diseases and treatments, particularly regarding vaccines and alternative therapies.